Advertisement
Advertisement
PTHS
Pelthos Therapeutics Inc.
28.36
USDSponsored
-1.09
-3.70%
Aug 07, 15:59 UTC -4
Closed
Pre-Market
28.36
0.00
0.00%
Pelthos Therapeutics Inc. Profile
About
Info & Links
CEO
Scott Plesha
Headquarters
DURHAM, NC 27703, UNITED STATES
Industry
Sector
Website
Auditor
Marcum LLP
Share holders
--
Employees
92
Pelthos Therapeutics Inc. Statistics
Valuation Measures
Market Capitalization2
98.57M
Enterprise Value
115.99M
Enterprise Value/EBITDA(ttm)
-2.94
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
2.71
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
58.89%
Operating Margin(ttm)
--
Profit Margin(ttm)
-135.97%
Return on Equity(ttm)
-123.54%
Return on Invested Capital(ttm)
-17.66%
Return on Assets(ttm)
-38.54%
Income Statement
Revenue(ttm)
27.70M
Revenue Per Share(ttm)
7.97
Gross Profit(ttm)
22.04M
EBITDA(ttm)3
-39.40M
Net Income Available to Common(ttm)
-51.59M
Diluted EPS(ttm)
-20.64
Share Statistics
Beta (5Y Monthly)
3.10
52-Week Change
48.95%
S&P 500 52-Week Change
21.72%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
3.48M
Dividend Yield
0.00%
Float4
3.04M
% Held by Insiders
12.70%
% Held by Institutions
77.96%
Balance Sheet
Total Cash(mrq)
32.23M
Total Cash Per Share(mrq)
9.27
Total Debt(mrq)
49.64M
Total Debt/Equity(mrq)
141.41%
Current Ratio(mrq)
2.79%
Quick Ratio(mrq)
1.86%
Book Value Per Share(mrq)
10.42
Cash Flow
Operating Cash Flow Per Share(ytd)
-3.96
Free Cash Flow(ytd)
-13.32M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement